# Revvity, Inc.: overview

RVTY · NYSE · CIK 31791 · [Technology](/sectors/technology.md) · fiscal year ends Dec 29

Pages: [Overview](/companies/rvty.md) · [Financials](/companies/rvty/financials.md) · [Filings](/companies/rvty/filings.md) · [Insiders](/companies/rvty/insiders.md)

Latest reported revenue: [$729.7m](/filings/0000031791-26-000027.md) for Q2 FY2026, three months to 2026-07-05, from the 10-Q filed Aug 11, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000031791-26-000027).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [684](/filings/0000031791-25-000037.md) | [729 d](/filings/0000031791-26-000012.md) | [665](/filings/0000031791-26-000019.md) | [720](/filings/0000031791-26-000027.md) | [699](/filings/0000031791-25-000037.md) | [772 d](/filings/0000031791-26-000012.md) | [711](/filings/0000031791-26-000019.md) | [730](/filings/0000031791-26-000027.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [14.3%](/filings/0000031791-25-000037.md) | [16.3% d](/filings/0000031791-26-000012.md) | [10.9%](/filings/0000031791-26-000019.md) | [12.6%](/filings/0000031791-26-000027.md) | [11.7%](/filings/0000031791-25-000037.md) | [14.5% d](/filings/0000031791-26-000012.md) | [10.7%](/filings/0000031791-26-000019.md) | [12.2%](/filings/0000031791-26-000027.md) |
| Net margin | % | [13.8%](/filings/0000031791-25-000037.md) | [13.0% d](/filings/0000031791-26-000012.md) | [6.4%](/filings/0000031791-26-000027.md) | [7.5%](/filings/0000031791-26-000027.md) | [6.7%](/filings/0000031791-25-000037.md) | [12.7% d](/filings/0000031791-26-000012.md) | [5.7%](/filings/0000031791-26-000027.md) | [7.1%](/filings/0000031791-26-000027.md) |
| Diluted EPS | $ per share | [0.77](/filings/0000031791-25-000037.md) | not reported | [0.35](/filings/0000031791-26-000019.md) | [0.46](/filings/0000031791-26-000027.md) | [0.40](/filings/0000031791-25-000037.md) | not reported | [0.36](/filings/0000031791-26-000019.md) | [0.47](/filings/0000031791-26-000027.md) |
| Free cash flow | $m | [126 d](/filings/0000031791-25-000037.md) | [150 d](/filings/0000031791-26-000012.md) | [112](/filings/0000031791-26-000019.md) | [115 d](/filings/0000031791-26-000027.md) | [120 d](/filings/0000031791-25-000037.md) | [162 d](/filings/0000031791-26-000012.md) | [95.5](/filings/0000031791-26-000019.md) | [181 d](/filings/0000031791-26-000027.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-01-02) | FY2022 (2023-01-01) | FY2023 (2023-12-31) | FY2024 (2024-12-29) | FY2025 (2025-12-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,828](/filings/0000031791-24-000004.md) | [3,312](/filings/0000031791-25-000009.md) | [2,751](/filings/0000031791-26-000012.md) | [2,755](/filings/0000031791-26-000012.md) | [2,856](/filings/0000031791-26-000012.md) |
| Gross margin | % | [63.6%](/filings/0000031791-23-000004.md) | [60.1%](/filings/0000031791-23-000004.md) | not reported | not reported | not reported |
| Operating margin | % | [32.9%](/filings/0000031791-24-000004.md) | [22.4%](/filings/0000031791-25-000009.md) | [10.9%](/filings/0000031791-26-000012.md) | [12.6%](/filings/0000031791-26-000012.md) | [12.5%](/filings/0000031791-26-000012.md) |
| Net margin | % | [24.6%](/filings/0000031791-24-000004.md) | [17.2%](/filings/0000031791-25-000009.md) | [25.2%](/filings/0000031791-26-000012.md) | [9.8%](/filings/0000031791-26-000012.md) | [8.4%](/filings/0000031791-26-000012.md) |
| Diluted EPS | $ per share | [8.08](/filings/0000031791-24-000004.md) | [4.50](/filings/0000031791-25-000009.md) | [5.55](/filings/0000031791-26-000012.md) | [2.20](/filings/0000031791-26-000012.md) | [2.07](/filings/0000031791-26-000012.md) |
| Free cash flow | $m | [1,325](/filings/0000031791-24-000004.md) | [594](/filings/0000031791-25-000009.md) | [9.9](/filings/0000031791-26-000012.md) | [542](/filings/0000031791-26-000012.md) | [509](/filings/0000031791-26-000012.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rvty/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Jupiter Topco LLC](/funds/2146052.md) | 2026-06-30 | $961.0m | 8,637,614 |  | Not compared |
| [EdgePoint Investment Group Inc.](/funds/1481669.md) | 2026-06-30 | $950.7m | 8,544,479 |  | Reduced −256,384 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $852.1m | 7,658,369 |  | Added +407,993 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $812.3m | 7,300,973 |  | Reduced −29,007 |
| [JANUS HENDERSON GROUP PLC](/funds/1274173.md) | 2026-03-31 | $731.4m | 8,348,127 |  | Not compared |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $530.8m | 4,770,448 |  | Reduced −42,719 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $483.2m | 4,342,739 |  | Added +32,426 |
| [VICTORY CAPITAL MANAGEMENT INC](/funds/1040188.md) | 2026-06-30 | $405.6m | 3,645,905 |  | Added +273,278 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $381.5m | 3,428,692 |  | Added +510,739 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $328.2m | 2,955,227 |  | Added +18,105 |

## Recent filings

[All 1,232 filings](/companies/rvty/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 20:06 ET | [10-Q](/filings/0000031791-26-000027.md) | Quarterly report, period 2026-07-05 | 0000031791-26-000027 |
| 2026-08-04 | 10:20 ET | [8-K](/filings/0000031791-26-000022.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000031791-26-000022 |
| 2026-05-12 | 20:07 ET | [10-Q](/filings/0000031791-26-000019.md) | Quarterly report, period 2026-04-05 | 0000031791-26-000019 |
| 2026-05-05 | 10:37 ET | [8-K](/filings/0000031791-26-000016.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000031791-26-000016 |
| 2026-05-01 | 20:05 ET | [8-K](/filings/0001193125-26-201401.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-201401 |
| 2026-03-16 | 12:01 ET | [DEF 14A](/filings/0001193125-26-107266.md) | Proxy statement, period 2026-04-28 | 0001193125-26-107266 |
| 2026-02-24 | 21:10 ET | [10-K](/filings/0000031791-26-000012.md) | Annual report, period 2025-12-28 | 0000031791-26-000012 |
| 2026-02-02 | 12:05 ET | [8-K](/filings/0000031791-26-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000031791-26-000007 |
| 2026-01-13 | 14:14 ET | [8-K](/filings/0000031791-26-000003.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0000031791-26-000003 |
| 2025-11-04 | 21:08 ET | [10-Q](/filings/0000031791-25-000037.md) | Quarterly report, period 2025-09-28 | 0000031791-25-000037 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 28, 2025](/filings/0000031791-26-000012.md), filed Feb 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 31791
- Tickers: RVTY
- Exchange: NYSE
- SIC code: 3826 Laboratory Analytical Instruments
- State of incorporation: MA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.